Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HBV Infection (HBeAg Negative)”

96 trials

Showing 20 of 96 results

Post-approval studies (Phase 4)Study completedNCT00487747
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 18
Not applicableUnknownNCT05494528
What this trial is testing

Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue Therapy

Who this might be right for
Chronic Hepatitis B Virus Infection
National Taiwan University Hospital 90
Post-approval studies (Phase 4)Study completedNCT00436163
What this trial is testing

Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 39
Post-approval studies (Phase 4)Study completedNCT00393484
What this trial is testing

A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 122
Large-scale testing (Phase 3)Study completedNCT02836236
What this trial is testing

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)

Who this might be right for
HBVChronic HBV Infection
Gilead Sciences 155
Post-approval studies (Phase 4)Study completedNCT02594293
What this trial is testing

Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370207
What this trial is testing

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

Who this might be right for
Hepatitis B, Chronic
AusperBio Therapeutics Inc. 84
Post-approval studies (Phase 4)Study completedNCT01787279
What this trial is testing

An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 59
Post-approval studies (Phase 4)Study completedNCT00324961
What this trial is testing

Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 533
Post-approval studies (Phase 4)Study completedNCT01379508
What this trial is testing

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Who this might be right for
Chronic Hepatitis B
Novartis Pharmaceuticals 241
Large-scale testing (Phase 3)Active Not RecruitingNCT07246889
What this trial is testing

Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 577
Not applicableUnknownNCT03643172
What this trial is testing

Terminator 2 Register

Who this might be right for
Chronic Hepatitis B, HBeAg Negative
Hannover Medical School 50
Testing effectiveness (Phase 2)Study completedNCT04129554
What this trial is testing

JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Janssen Sciences Ireland UC 130
Post-approval studies (Phase 4)UnknownNCT02838810
What this trial is testing

The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 200
Testing effectiveness (Phase 2)Study completedNCT01524679
What this trial is testing

Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen

Who this might be right for
Chronic Hepatitis B
Johannes Gutenberg University Mainz 170
Large-scale testing (Phase 3)Ended earlyNCT00313274
What this trial is testing

Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV

Who this might be right for
Hepatitis B
Bukwang Pharmaceutical 80
Not applicableUnknownNCT03123653
What this trial is testing

To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy.

Who this might be right for
Hepatitis B
Institute of Liver and Biliary Sciences, India 118
Large-scale testing (Phase 3)Ended earlyNCT01641926
What this trial is testing

The Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)

Who this might be right for
Hepatitis B, Chronic
Merck Sharp & Dohme LLC 402
Testing effectiveness (Phase 2)Study completedNCT02881008
What this trial is testing

Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Hepatera Ltd. 48
Post-approval studies (Phase 4)Study completedNCT02791269
What this trial is testing

Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 24
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation